CAPD治疗糖尿病肾病尿毒症临床疗效观察  

Observation on the clinical effect of continuous ambulatory peritoneal dialy- sis to diabetic nephropathy uremia

作　　者：余长江[1] 

机构地区：[1]江苏省睢宁县人民医院,江苏睢宁221200

出　　处：《中国当代医药》2008年第24期40-41,共2页China Modern Medicine

摘　　要：目的：讨论糖尿病肾病尿毒症患者腹膜透析的临床疗效。方法：对28例糖尿病肾病尿毒症患者进行非卧床持续性腹膜透析（CAPD）治疗，观察CAPD前后的临床和生化指标、生存率、主要并发症等。结果：CAPD可以显著改善患者尿毒症症状及重要生化指标，1年和2年生存率分别为64.3％、57．1％，血糖控制良好。结论：CAPD治疗糖尿病肾病尿毒症安全有效，腹腔注射胰岛素血糖控制良好，可以在家中进行透析，患者生活质量较高。Objective： To inverstigate the clincal effect of CAPD to patients with diabetic nephropathy uremia. Methods： 28 patients with diabetic nephropathy uremia were treated by CAPD, observed the survival rate main complications. Clinical and biochemical standards ctc. Results： CAPD can significantly improve uremia symptoms and main biochemical standards. The survival rate of one year and two years is 64.3%-57.1%. Conclusion： CAPD to diabetic nephropathy is secure and effective, it can be done at home. The living quality is high.

关 键 词：尿毒症 糖尿病肾病 非卧床持续性腹膜透析 

分 类 号：R587.2[医药卫生—内分泌]